SAba Sile
Corporate Officer/Principal at SPRUCE BIOSCIENCES, INC.
Profile
SAba Sile is currently the Vice President-Clinical Development at Spruce Biosciences, Inc. Prior to this, Sile worked as a Medical Director at BioMarin Pharmaceutical, Inc. and as an Executive Medical Director-Clinical Development at Horizon Therapeutics Plc.
Sile holds a doctorate degree from the University of Pittsburgh School of Medicine.
SAba Sile active positions
| Companies | Position | Start |
|---|---|---|
| SPRUCE BIOSCIENCES, INC. | Corporate Officer/Principal | 09/11/2022 |
Former positions of SAba Sile
| Companies | Position | End |
|---|---|---|
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Corporate Officer/Principal | - |
| BIOMARIN PHARMACEUTICAL INC. | Corporate Officer/Principal | - |
Training of SAba Sile
| University of Pittsburgh School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Health Technology |
| SPRUCE BIOSCIENCES, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Horizon Therapeutics Plc
 Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
- Stock Market
- Insiders
- SAba Sile
